Search research articles
Contact Us
Filters
Showing results (81-90 of 119) with videos related to
Page
of 12
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
August 20, 2003
Evidence for a primary islet autoantigen (preproinsulin 1) for insulitis and diabetes in the nonobese diabetic mouse
Hiroaki Moriyama, Norio Abiru, Johanna Paronen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 11, 2015
Effects of Gluten Intake on Risk of Celiac Disease: A Case-Control Study on a Swedish Birth Cohort
Carin Andrén Aronsson, Hye-Seung Lee, Sibylle Koletzko, et al.
Annals of the New York Academy of Sciences
|
December 18, 2003
In vivo expression of B:9-23 peptide/I-A(g7) complex may abrogate the inhibition of diabetes induced by RGD-fiber-mutant adenovirus in NOD mice
Norio Abiru, Fuyan Sun, Eiji Kawasaki, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
March 16, 2004
Fluctuating transglutaminase autoantibodies are related to histologic features of celiac disease
Edwin Liu, Fei Bao, Katherine Barriga, et al.
Autoimmunity Reviews
|
July 10, 2003
Insulin autoimmunity: prediction/precipitation/prevention type 1A diabetes
George S Eisenbarth, Hiroaki Moriyama, David T Robles, et al.
Nature
|
May 13, 2005
Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice
Maki Nakayama, Norio Abiru, Hiroaki Moriyama, et al.
Autoimmune Diseases
|
April 12, 2014
Exploring T cell reactivity to gliadin in young children with newly diagnosed celiac disease
Edwin Liu, Kristen McDaniel, Stephanie Case, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 7, 2007
Altered B:9-23 insulin, when administered intranasally with cholera toxin adjuvant, suppresses the expression of insulin autoantibodies and prevents diabetes
Masakazu Kobayashi, Norio Abiru, Takeshi Arakawa, et al.
Patient Related Outcome Measures
|
February 19, 2026
Psychometric Evaluation of the Celiac Disease Symptom Diary 2.1<sup>©</sup> Using Data from the Virtual Celiac Symptoms Study
Sonal Ghura, Dawn Wiese Adams, Marilyn G Geller, et al.
Scandinavian Journal of Gastroenterology
|
September 17, 2020
Childhood growth prior to screen-detected celiac disease: prospective follow-up of an at-risk birth cohort
Marisa G Stahl, Fran Dong, Molly M Lamb, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 119) with videos related to
Sort By:
Page
of 12
Proceedings of the National Academy of Sciences of the United States of America
|
August 20, 2003
Evidence for a primary islet autoantigen (preproinsulin 1) for insulitis and diabetes in the nonobese diabetic mouse
Hiroaki Moriyama, Norio Abiru, Johanna Paronen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 11, 2015
Effects of Gluten Intake on Risk of Celiac Disease: A Case-Control Study on a Swedish Birth Cohort
Carin Andrén Aronsson, Hye-Seung Lee, Sibylle Koletzko, et al.
Annals of the New York Academy of Sciences
|
December 18, 2003
In vivo expression of B:9-23 peptide/I-A(g7) complex may abrogate the inhibition of diabetes induced by RGD-fiber-mutant adenovirus in NOD mice
Norio Abiru, Fuyan Sun, Eiji Kawasaki, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
March 16, 2004
Fluctuating transglutaminase autoantibodies are related to histologic features of celiac disease
Edwin Liu, Fei Bao, Katherine Barriga, et al.
Autoimmunity Reviews
|
July 10, 2003
Insulin autoimmunity: prediction/precipitation/prevention type 1A diabetes
George S Eisenbarth, Hiroaki Moriyama, David T Robles, et al.
Nature
|
May 13, 2005
Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice
Maki Nakayama, Norio Abiru, Hiroaki Moriyama, et al.
Autoimmune Diseases
|
April 12, 2014
Exploring T cell reactivity to gliadin in young children with newly diagnosed celiac disease
Edwin Liu, Kristen McDaniel, Stephanie Case, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 7, 2007
Altered B:9-23 insulin, when administered intranasally with cholera toxin adjuvant, suppresses the expression of insulin autoantibodies and prevents diabetes
Masakazu Kobayashi, Norio Abiru, Takeshi Arakawa, et al.
Patient Related Outcome Measures
|
February 19, 2026
Psychometric Evaluation of the Celiac Disease Symptom Diary 2.1<sup>©</sup> Using Data from the Virtual Celiac Symptoms Study
Sonal Ghura, Dawn Wiese Adams, Marilyn G Geller, et al.
Scandinavian Journal of Gastroenterology
|
September 17, 2020
Childhood growth prior to screen-detected celiac disease: prospective follow-up of an at-risk birth cohort
Marisa G Stahl, Fran Dong, Molly M Lamb, et al.
Page
of 12